VBIO
Valion Bio (VBIO)
NASDAQ
$0.64-$0.02 (-2.54%)
Price as of Jun 03, 2026 4:47 PM EDT
  • $2.5M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
780,000
-33.67%
1.2M
-36.09%
1.8M
N/A
Cost of Revenue
N/A
N/A
778,000
-12.49%
889,000
-42.31%
1.5M
N/A
Gross Profit
0
-100.00%
2,000
-99.30%
287,000
-4.01%
299,000
N/A
Sales and Marketing Expense
4.8M
+301.60%
1.2M
-44.14%
2.1M
-23.89%
2.8M
N/A
Research and Development Expense
-3.1M
+138.46%
-1.3M
-20.66%
-1.7M
-4.34%
-1.7M
N/A
Depreciation and Amortization Expense
5,000
+66.67%
3,000
-62.50%
8,000
-20.00%
10,000
N/A
Total Operating Expenses
7.9M
+39.47%
5.7M
-33.63%
8.5M
-17.94%
10.4M
N/A
Operating Profit
-7.9M
+39.52%
-5.7M
-31.34%
-8.2M
-18.35%
-10.1M
N/A
Interest Income
23,000
N/A
N/A
N/A
N/A
N/A
162,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
23,000
N/A
0
N/A
0
-100.00%
162,000
N/A
Total Nonoperating Income and Expense
-95,000
-1,683.33%
6,000
+500.00%
1,000
-50.00%
2,000
N/A
Income before Taxes
-8.0M
+41.19%
-5.7M
-31.33%
-8.2M
-18.36%
-10.1M
N/A
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.9M
+56.99%
-5.7M
-31.40%
-8.2M
-18.34%
-10.1M
N/A
Net Income from Continuing Operations Applicable to Common
-8.0M
+41.34%
-5.7M
-31.40%
-8.2M
-18.34%
-10.1M
N/A
Basic EPS and Net Income
-7.84
-60.16%
-19.68
+89.23%
-10.40
+900.00%
-1.04
N/A
Diluted EPS and Net Income
-7.84
-60.16%
-19.68
+89.23%
-10.40
+900.00%
-1.04
N/A
Basic Weighted Average Shares
1.2M
+302.11%
287,370
-63.76%
793,043
-91.80%
9.7M
N/A
Diluted Weighted Average Shares
1.2M
+302.11%
287,370
-63.76%
793,043
-91.80%
9.7M
N/A
Balance Sheet
Cash and Cash Equivalents
12.6M
+531.62%
2.0M
-41.03%
3.4M
-3.47%
3.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
12.6M
+531.62%
2.0M
-41.03%
3.4M
-3.47%
3.5M
N/A
Total Current Assets
13.0M
+392.84%
2.6M
-43.27%
4.7M
-12.01%
5.3M
N/A
Accumulated Depreciation
15,000
-62.50%
40,000
+8.11%
37,000
N/A
N/A
N/A
Property and Plant and Equipment and Net
12.6M
+10,522.69%
119,000
-2.46%
122,000
+916.67%
12,000
N/A
Total Long-Term Assets
124,000
+264.71%
34,000
0.00%
34,000
0.00%
34,000
N/A
Total Assets
31.6M
+1,026.01%
2.8M
-45.57%
5.2M
-11.94%
5.9M
N/A
Income Taxes Payable
180,000
+12.50%
160,000
0.00%
160,000
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
646,000
+137.50%
272,000
-80.59%
1.4M
-24.64%
1.9M
N/A
Total Long-Term Debt
6.5M
N/A
N/A
N/A
N/A
N/A
450,000
N/A
Total Long-Term Liabilities
48,000
-78.67%
225,000
+27.84%
176,000
-52.04%
367,000
N/A
Total Liabilities
7.4M
+2,635.29%
272,000
-82.75%
1.6M
-29.16%
2.2M
N/A
Retained Earnings
-52.6M
+20.80%
-43.5M
+14.93%
-37.9M
+27.81%
-29.6M
N/A
Total Stockholders Equity
16.8M
+562.60%
2.5M
-29.19%
3.6M
-1.38%
3.6M
N/A
Total Shares Outstanding
2.5M
+353.48%
556,978
-62.01%
1.5M
-84.85%
9.7M
N/A
Cash Flow
Cash from Operating Activities
-7.0M
+22.25%
-5.7M
-32.73%
-8.5M
-4.57%
-8.9M
N/A
Capital Expenditures
38,000
-67.80%
118,000
0.00%
118,000
+972.73%
11,000
N/A
Cash from Investing Activities
-705,000
+497.46%
-118,000
0.00%
-118,000
+972.73%
-11,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
18.3M
+323.52%
4.3M
-49.08%
8.5M
+1,711.17%
-528,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
0.26%
-98.95%
24.40%
N/A
N/A
N/A
Operating Margin
N/A
N/A
-725.77%
+3.52%
-701.11%
N/A
N/A
N/A
Return on Assets
-51.60%
-63.67%
-142.01%
-5.14%
-149.71%
N/A
N/A
N/A
Return on Equity
-91.85%
-50.34%
-184.95%
-19.12%
-228.68%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
-33.67%
-6.69%
-36.09%
N/A
N/A
N/A
Current Ratio
20.13
+107.51%
9.70
+192.19%
3.32
N/A
N/A
N/A
Cash Ratio
19.57
+165.94%
7.36
+203.73%
2.42
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow